Analysis of the human CD21 transcription unit reveals differential splicing of exon 11 in mature transcripts and excludes alternative splicing as the mechanism causing solubilization of CD21

Molecular Immunology

Volumn 34, Issue 10, 1997, Pages 683-693

  Illges, Harald ^a   Braun, Moritz ^a   Peter, Hans H ^a   Melchers, Inga ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Alternative splicing; CD21; CR2; Exon 11; Soluble CD21

Indexed keywords

COMPLEMENT COMPONENT C3D RECEPTOR; MESSENGER RNA;

ALTERNATIVE RNA SPLICING; ANTIGEN BINDING; ANTIGEN EXPRESSION; ARTICLE; EPSTEIN BARR VIRUS; EXON; HUMAN; HUMAN CELL; IMMUNOREGULATION; MEMBRANE BINDING; MOLECULAR WEIGHT; NORMAL HUMAN; PRIORITY JOURNAL; TRANSCRIPTION REGULATION;

ALTERNATIVE SPLICING; B-LYMPHOCYTES; BASE SEQUENCE; BONE MARROW; CELLS, CULTURED; CLONING, MOLECULAR; EXONS; HUMANS; INTRONS; JURKAT CELLS; MOLECULAR SEQUENCE DATA; POLYMERASE CHAIN REACTION; RECEPTORS, COMPLEMENT 3D; RNA SPLICING; RNA, MESSENGER; SEQUENCE HOMOLOGY, NUCLEIC ACID; SPLEEN; T-LYMPHOCYTES; TONSIL; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED;

HUMAN HERPESVIRUS 4;

EID: 0031465442     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0161-5890(97)00099-0     Document Type: Article

References (55)

1. Ahearn J. M., Fischer M. B., Croix D., Goerg S., Ma M. H., Xia J. R., Zhou X. N., Howard R. G., Rothstein T. L., Carroll M. C. (1996) Disruption of the CR2 locus results in a reduction in B-1a cells and in an impaired B cell response to T-dependent antigen. Immunity 4(3), 251-262.
2. Aubry J. P., Pochon S., Graber P., Jansen K. U., Bonnefoy J. Y. (1992) CD21 is a ligand for CD23 and regulates IgE production. Nature 358(6386), 505-507.
3. Aubry J. P., Shields J. G., Jansen K. U., Bonnefoy J. Y. (1993) A multiparameter flow cytometric method to study surface molecules involved in interactions between subpopulations of cells. J. Immun. Methods 159(1-2), 161-171.
4. Bacon K., Gauchat J. F., Aubry J. P., Pochon S., Graber P., Henchoz S., Bonnefoy J. Y. (1993) CD21 expressed on basophilic cells is involved in histamine release triggered by CD23 and anti-CD21 antibodies. Eur. J. Immun. 23(10), 2721-2724.
5. Behr S. and Schriever F. (1995) Engaging CD19 or target of an antiproliferative antibody 1 on human B lymphocytes induces binding of B cells to the interfollicular stroma of human tonsils via intergrin a4/b1 and fibronnectin. J. exp. Med. 182, 1191-1199.
6. Björk P., Elenström A., Magnusson C., Rosen A., Severinson E. and Paulie S. (1993) CD23 and CD21 function as adhesion molecules in homotypic aggregation of human lymphocytes. Eur. J. Immun. 23, 1771-1775.
7. Bohnsack J. F., Cooper N. R. (1988) CR2 ligands modulate human B cell activation. J. Immun. 141(8), 2569-2576.
8. Bonnefoy J. Y., Henchoz S., Hardie D., Holder M. J., Gordon J. (1993) A subset of anti-CD21 antibodies promotes the rescue of germinal center B cells from apoptosis. Eur. J. Immun. 23(4), 969-972.
9. Boyer V., Delibrias C., Noraz N., Fischer E., Kazatchkine M. D., Desgranges C. (1992) Complement receptor type 2 mediates infection of the human CD4-negative Raji B-cell line with opsonized HIV. Scand. J. Immun. 36(6), 879-883.
10. Carel J. C., Myones B. L., Frazier B., Holers V. M. (1990) Structural requirements for C3d,g/Epstein-Barr virus receptor (CR2/CD21) ligand binding, internalization, and viral infection. J. biol. Chem. 265(21), 12293-12299.
11. Carter R. H. and Fearon D. T. (1992) CD19: lowering the threshold for antigen receptor stimulation of B lymphocytes. Science 256, 105-107.
12. Carter R. H., Spycher M. O., Ng Y. C., Hoffman R., Fearon D. T. (1988) Synergistic interaction between complement receptor type 2 and membrane IgM on B lymphocytes. J. Immun. 141(2), 457-463.
13. Croix D. A., Ahearn J. M., Rosengard A. M., Han S., Kelsoe G., Ma M. and Carroll M. C. (1996) Antibody response to a T-dependent antigen requires B cell expression of complement receptors. J. exp. Med. 183, 1857-1864.
14. Delcayre A. X., Salas F., Mathur S., Kovats K., Lotz M., Lernhardt W. (1991) Epstein Barr virus/complement C3d receptor is an interferon alpha receptor. EMBO J. 10(4), 919-926.
15. Fearon D. T. and Carter R. H. (1995) The CD19/CR2/TAPA-1 complex of B lymphocytes: linking natural to acquired immunity. A. Rev. Immun. 13, 127-149.
16. Findley H. Jr., Cooper M. D., Kim T. H., Alvarado C., Ragab A. H. (1982) Two new acute lymphoblastic leukemia cell lines with early B-cell phenotypes. Blood 60(6), 1305-1309.
17. Frade R., Myones B. L., Barel M., Krikorian L., Charriaut C., Ross G. D. (1985) gp140, a C3b-binding membrane component of lymphocytes, is the B cell C3dg/C3d receptor (CR2) and is distinct from the neutrophil C3dg receptor (CR4). Eur. J. Immun. 15(12), 1192-1197.
18. Fremeauxbacchi V., Bernard I., Maillet F., Mani J. C., Fontaine M., Bonnefoy J. Y., Kazatchkine M. D., Fischer E. (1996) Human lymphocytes shed a soluble form of cd21 (the c3dg/Epstein-Barr virus receptor, cr2) that binds ic3b and cd23. Eur. J. Immun. 26(7), 1497-1503.
19. Fujisaku A., Harley J. B., Frank M. B., Gruner B. A., Frazier B., Holers V. M. (1989) Genomic organization and polymorphisms of the human C3d/Epstein-Barr virus receptor. J. biol. Chem. 264(4), 2118-2215.
20. Gasque P., Chan P., Mauger C., Schouft M. T., Singhrao S., Dierich M. P., Morgan B. P., Fontaine M. (1996) Identification and characterization of complement c3 receptors on human astrocytes. J. Immun. 156(6), 2247-2255.
21. Hebell T., Ahearn J. M., Fearon D. T. (1991) Suppression of the immune response by a soluble complement receptor of B lymphocytes. Science 254(5028), 102-105.
22. Heyman B., Wiersma E. J., Kinoshita T. (1990) In vivo inhibition of the antibody response by a complement receptor-specific monoclonal antibody. J. exp. Med. 172(2), 665-668.
23. Holers V. M., Kinoshita T., And Molina H. (1992) The evolution of mouse and human complement C3-binding proteins: divergence of form but conservation of function. Immun. Today 13(6), 231-236.
24. Huemer H. P., Larcher C., Prodinger W. M., Petzer A.-L., Mitterer M. and Falser N. (1993) Determination od soluble CD21 as a parameter for B cell activation. Clin. exp. Immun. 93, 195-199.
25. Illges H., Braun M., Peter H. H., Melchers I. (1996) A plasmid for the quantification of the cd21 human interferon-alpha receptor expression by PCR. Eur. Cytokine Netw. 7(3), 375-376.
26. Kaneko T., Fukuda J., Yoshihara T., Zheng H., Mori S., Mizoguchi H., Oshimi K. (1995) Nasal natural killer (NK) cell lymphoma: report of a case with activated NK cells containing Epstein-Barr virus and expressing CD21 antigen, and comparative studies of their phenotype and cytotoxicity with normal NK cells. Br. J. Haemat. 91(2), 355-361.
27. Korsmeyer S. J., Arnold A., Bakhshi A., Ravetch J. V., Siebenlist U., Hieter P. A., Sharrow S. O., LeBien T. W., Kersey J. H., Poplack D. G., Leder P., Waldmann T. A. (1983) Immunoglobulin gene rearrangement and cell surface antigen expression in acute lymphocytic leukemias of T cell and B cell precursor origins. J. clin. Invest. 71(2), 301-313.
28. Kozono Y., Duke R. C., Schleicher M. S., Holers V. M. (1995) Co-ligation of mouse complement receptors 1 and 2 with surface IgM rescues splenic B cells and WEHI-231 cells from anti-surface IgM-induced apoptosis. Eur. J. Immun. 25(4), 1013-1017.
29. Lambris J. D., Dobson N. J., Ross G. D. (1981) Isolation of lymphocyte membrane complement receptor type two (the C3d receptor) and preparation of receptor-specific antibody. Proc. natn. Acad. Sci. U.S.A. 78(3), 1828-1832.
30. Lassoued K., Nunez C. A., Billips L., Kubagawa H., Monteiro R. C., LeBien T. W., Cooper M. D. (1993) Expression of surrogate light chain receptors is restricted to a late stage in pre-B cell differentiation. Cell 73(1), 73-86.
31. Ling N. R., Brown B. (1992) Properties of soluble CR2 in human serum. Immunobiology 185(2-4), 403-414.
32. Ling N., Hansel T., Richardson P., Brown B. (1991) Cellular origins of serum complement receptor type 2 in normal individuals and in hypogammaglobulinaemia. Clin. exp. Immun. 84(1), 16-22.
33. Liu Y. J., Xu J. C., Debouteiller O., Parham C. L., Grouard G., Djossou O., Desaintvis B., Lebecque S., Banchereau J., Moore K. W. (1997) Follicular dendritic cells specifically express the long Cr2/Cd21 isoform. J. exp. Med. 185(1), 165-170.
34. Lowe J., Brown B., Hardie D., Richardson P. and Ling N. (1989) Soluble forms of CD21 and CD23 antigens in the serum in B cell chronic lymphocytic leukemia. Immun. Lett. 20, 103-110.
35. Lowell C. A., Klickstein L. B., Carter R. H., Mitchell J. A., Fearon D. T., Ahearn J. M. (1989) Mapping of the Epstein-Barr virus and C3dg binding sites to a common domain on complement receptor type 2. J. exp. Med. 170(6), 1931-1946.
36. Molina H., Holers V. M., Li B., Fang Y. F., Mariathasan S., Goellner J., Straussschoenberger J., Karr R. W., Chaplin D. D. (1996) Markedly impaired humoral immune response in mice deficient in complement receptors 1 and 2. Proc. natn. Acad. Sci. U.S.A. 93(8), 3357-3361.
37. Montefiori D. C., Zhou J., Shaff D. I. (1992) CD4-independent binding of HIV-1 to the B lymphocyte receptor CR2 (CD21) in the presence of complement and antibody. Clin. exp. Immun. 90(3), 383-389.
38. Moore M. D., Cooper N. R., Tack B. F., Nemerow G. R. (1987) Molecular cloning of the cDNA encoding the Epstein-Barr virus/C3d receptor (complement receptor type 2) of human B lymphocytes. Proc. natn. Acad. Sci. U.S.A. 84(24), 9194-9198.
39. Nemerow G. R., Wolfert R., McNaughton M. E., Cooper N. R. (1985) Identification and characterization of the Epstein-Barr virus receptor on human B lymphocytes and its relationship to the C3d complement receptor (CR2). J. Virol. 55(2), 347-351.
40. Pepys M. B. (1974) Role of complement in induction of antibody production in vivo. Effect of cobra factor and other C3-reactive agents on thymus-dependent and thymus-independent antibody responses. J. exp. Med. 140(1), 126-145.
41. Raff M. C., Megson M., Owen J. J., Cooper M. D. (1976) Early production of intracellular IgM by B-lymphocyte precursors in mouse. Nature 259(5540), 224-226.
42. Reynes M., Aubert J. P., Cohen J. H., Audouin J., Tricottet V., Diebold J., Kazatchkine M. D. (1985) Human follicular dendritic cells express CR1, CR2, and CR3 complement receptor antigens. J. Immun. 135(4), 2687-2694.
43. Smith R. G., Dev V. G., Shannon W. Jr. (1981) Characterization of a novel human pre-B leukemia cell line. J. Immun. 126(2), 596-602.
44. Stephens R. M. and Schneider T. D. (1992) Features of spliceosome evolution and function inferred from an analysis of the information at human splice sites. J. molec. Biol. 228, 1124-1136.
45. Stong R. C., Korsmeyer S. J., Parkin J. L., Arthur D. C., Kersey J. H. (1985) Human acute leukemia cell line with the t(4;11) chromosomal rearrangement exhibits B lineage and monocytic characteristics. Blood 65(1), 21-31.
46. Tedder T. F., Clement L. T., Cooper M. D. (1984) Expression of C3d receptors during human B cell differentiation: immunofluorescence analysis with the HB-5 monoclonal antibody. J. Immun. 133(2), 678-683.
47. Thyphronitis G., Kinoshita T., Inoue K., Schweinle J. E., Tsokos G. C., Metcalf E. S., Finkelman F. D., Balow J. E. (1991) Modulation of mouse complement receptors 1 and 2 suppresses antibody responses in vivo. J. Immun. 147(1), 224-230.
48. Toothaker L. E., Henjes A. J., Weis J. J. (1989) Variability of CR2 gene products is due to alternative exon usage and different CR2 alleles. J. Immun. 142(10), 3668-3675.
49. Tsoukas C. D., Lambris J. D. (1988) Expression of CR2/EBV receptors on human thymocytes detected by monoclonal antibodies. Eur. J. Immun. 18(8), 1299-1302.
50. Weis J. J., Tedder T. F., Fearon D. T. (1984) Identification of a 145,000 Mr membrane protein as the C3d receptor (CR2) of human B lymphocytes. Proc. natn. Acad. Sci. U.S.A. 81(3), 881-885.
51. Weis J. J., Toothaker L. E., Smith J. A., Weis J. H., Fearon D. T. (1988) Structure of the human B lymphocyte receptor for C3d and the Epstein-Barr virus and relatedness to other members of the family of C3/C4 binding proteins (published erratum appears in J. exp. Med. 1988 168(5) 1953-1954). J. exp. Med. 167(3), 1047-1066.
52. Wieringa B., Hofer E., Weissmann C. (1984) A minimal intron length but no specific internal sequence is required for splicing the large rabbit beta-globin intron. Cell 37(3), 915-925.
53. Wiersma E. J., Kinoshita T., Heyman B. (1991) Inhibition of immunological memory and T-independent humoral responses by monoclonal antibodies specific for murine complement receptors. Eur. J. Immun. 21(10), 2501-2506.
54. Wilson J. G., Tedder T. F., Fearon D. T. (1983) Characterization of human T lymphocytes that express the C3b receptor. J. Immun. 131(2), 684.
55. Young L. S., Clark D., Sixbey J. W., Rickinson A. B. (1986) Epstein-Barr virus receptors on human pharyngeal epithelia. Lancet 1(8475), 240-242.